Home › Schizophrenia › Virginia › Richmond
Schizophrenia clinical trials in Richmond, VA
6 studies for Schizophrenia are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Virginia Commonwealth University, Richmond
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Local Institution - 0050, Richmond
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Richmond
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
RecruitingPhase 3
- Local Institution - 0050, Richmond
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- Local Institution - 0045, Petersburg · 23 mi away
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
RecruitingPhase 3
- Alkermes Investigational Site, Richmond
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL20 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Hialeah, FL13 studies
- San Diego, CA13 studies
- New York City, NY13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Cardiovascular Disease13 studies
- Colorectal Cancer13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Obesity11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.